Home Other Building Blocks 58534-64-8
58534-64-8,MFCD00017516
Catalog No.:AA00EGM5

58534-64-8 | 3,4-DIACETOXY-BENZOIC ACID

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
95%
3 weeks  
$184.00   $129.00
- +
100mg
95%
3 weeks  
$225.00   $158.00
- +
250mg
95%
3 weeks  
$272.00   $190.00
- +
500mg
95%
3 weeks  
$408.00   $285.00
- +
1g
95%
3 weeks  
$545.00   $382.00
- +
2.5g
95%
3 weeks  
$961.00   $673.00
- +
5g
95%
3 weeks  
$1,367.00   $957.00
- +
10g
95%
3 weeks  
$1,972.00   $1,380.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00EGM5
Chemical Name:
3,4-DIACETOXY-BENZOIC ACID
CAS Number:
58534-64-8
Molecular Formula:
C11H10O6
Molecular Weight:
238.1935
MDL Number:
MFCD00017516
SMILES:
CC(=O)Oc1cc(ccc1OC(=O)C)C(=O)O
Properties
Properties
 
Form:
Solid  

Computed Properties
 
Complexity:
324  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
5  
XLogP3:
1.2  

Downstream Synthesis Route

[1]Locationinpatent:experimentalpartZhang,Qingzhi;Raheem,K.Saki;Botting,NigelP.;Slawin,AlexandraM.Z.;Kay,ColinD.;O'Hagan,David[Tetrahedron,2012,vol.68,#22,p.4194-4201]

[2]Li,Yu-Wen;Ma,Cui-Li[JournaloftheSerbianChemicalSociety,2016,vol.81,#1,p.23-28]

[3]Schmidt,Ulrich;Wild,Jochen[LiebigsAnnalenderChemie,1985,#9,p.1882-1894]

[4]LeBlanc,LucM.;Pare,AurelieF.;Jean-Francois,Jacques;Hebert,MartinJ.G.;Surette,MarcE.;Touaibia,Mohamed[Molecules,2012,vol.17,#12,p.14637-14650]

[5]Priem,Christoph;Geyer,Armin[Chemistry-AEuropeanJournal,2019,vol.25,#63,p.14278-14283]

[6]Sun,Xiao-Liang;Wang,Shi-Yu;Qi,Zhi-Min;Wan,Ning;Zhang,Bang-Le;He,Wei[ResearchonChemicalIntermediates,2016,vol.42,#10,p.7659-7673]

[7]CurrentPatentAssignee:SHINPOONGPHARMACEUTICALCOLTD-EP3345910,2018,A1Locationinpatent:Paragraph0034

[8]Degotte,Gilles;Francotte,Pierre;Pirotte,Bernard;Frédérich,Michel[ArchivderPharmazie,2021,vol.354,#11]

[9]Malkin;Nierenstein[ChemischeBerichte,1928,vol.61,p.798][JournaloftheAmericanChemicalSociety,1931,vol.53,p.239]Lesser;Gad[ChemischeBerichte,1926,vol.59,p.234]

[10]Fischer,E.;Bergmann;Lipschitz[ChemischeBerichte,1918,vol.51,p.71]

[11]Tobe,Masanori;Isobe,Yoshiaki;Goto,Yuso;Obara,Fumihiro;Tsuchiya,Masami;Matsui,Junko;Hirota,Kosaku;Hayashi,Hideya[BioorganicandMedicinalChemistry,2000,vol.8,#8,p.2037-2047]

[12]Gita,Haruhisa;Sobe,Yoshiaki;Akaku,Haruo;Ekine,Rena;Oto,Yuso;Isawa,Satoru;Hayashi,Hideya[BioorganicandMedicinalChemistryLetters,2001,vol.11,#4,p.549-551]

[13]Lin,Chi-Fu;Chang,Tsu-Chung;Chiang,Chih-Chia;Tsai,Hou-Jen;Hsu,Ling-Yih[ChemicalandPharmaceuticalBulletin,2005,vol.53,#11,p.1402-1407]Chang-Xiao;Mouscadet,Jean-Francois;Chiang,Chih-Chia;Tsai,Hou-Jen;Hsu,Ling-Yih[ChemicalandPharmaceuticalBulletin,2006,vol.54,#5,p.682-686]

[14]Nomura,Eisaku;Hosoda,Asao;Taniguchi,Hisaji[JournalofOrganicChemistry,2001,vol.66,#24,p.8030-8036]

[15]Locationinpatent:schemeortableRho,HoSik;Baek,HeungSoo;Ahn,SooMi;Yoo,JaeWon;Kim,DuckHee;Kim,HanGon[BioorganicandMedicinalChemistryLetters,2009,vol.19,#5,p.1532-1533]

[16]Wang,Peng;Liu,Chuan;Sanches,Tino;Zhong,Yuan;Liu,Bo;Xiong,Junlong;Neamati,Nouri;Zhao,Guisen[BioorganicandMedicinalChemistryLetters,2009,vol.19,#16,p.4574-4578]

[17]CurrentPatentAssignee:KONINKLIJKEDSMN.V.-WO2010/37045,2010,A1Locationinpatent:Page/Pagecolumn55-56

[18]Yu,Shenghui;Zhang,Linna;Yan,Shifeng;Wang,Peng;Sanchez,Tino;Christ,Frauke;Debyser,Zeger;Neamati,Nouri;Zhao,Guisen[JournalofEnzymeInhibitionandMedicinalChemistry,2012,vol.27,#5,p.628-640]

[19]CurrentPatentAssignee:VENATORXPHARMACEUTICALSINC-US2014/194386,2014,A1Locationinpatent:Paragraph0481

[20]Xue,Song;Seki,Hajime;Remes,Marek;Šilhár,Peter;Janda,Kim[BioorganicandMedicinalChemistryLetters,2017,vol.27,#22,p.4956-4959]

[21]Lü,Zirui;Li,Xiaona;Li,Kebin;Wang,Cong;Du,Tingting;Huang,Wei;Ji,Ming;Li,Changhong;Xu,Fengrong;Xu,Ping;Niu,Yan[ACSMedicinalChemistryLetters,2021,vol.12,#5,p.696-703]

[1]LiebigsAnnalenderChemie,1984,p.401-406

[1]LiebigsAnnalenderChemie,1984,p.401-406

[2]LiebigsAnnalenderChemie,1984,p.401-406

[1]LiebigsAnnalenderChemie,1984,p.1024-1035

58534-64-8    112914-13-3   
N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)-3,4-dihydroxybenzamide 

[1]Patent:EP3345910,2018,A1.Locationinpatent:Paragraph0038

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:58534-64-8 Molecular Formula|58534-64-8 MDL|58534-64-8 SMILES|58534-64-8 3,4-DIACETOXY-BENZOIC ACID